Compared with the myocarditis group, the expression of Smad2 and p-Samd2 protein tended to decrease in the BMSCs treatment group, but the difference between the two groups was not statistically significant (Figures 5(b) and 5(c)). The gene discussed is SMAD2; the disease is myocarditis.